Sort
21,453 grants matching “tuberculosis”
Mali International Center for Excellence in Research: Filariasis
$94,563Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Mathematical Techniques for Control of Epidemic Trypanosoma cruzi Transmission
$94,531Michael Z Levy · University Of Pennsylvania · K01 · FY2008 · AI
AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAM
$94,515Weill Medical College Of Cornell Univ · D43 · FY2005 · TW
Teens on TB Treatment: Predicting Adherence through Clinical Decision Analysis
$94,438Silvia Shinpei Chiang · Rhode Island Hospital · K01 · FY2021 · TW
Dissection of Mycobacterium tuberculosis Clp protease assembly, activity and regulation
$94,385Karl Robert Schmitz · University Of Delaware · P20 · FY2024 · GM
TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity
$94,312Jonathan E Golub · Johns Hopkins University · R01 · FY2025 · AI
Investigating bacterial contributions to TB treatment response: a focus on in-host pathogen dynamics
$94,308Maha Farhat · Harvard Medical School · R01 · FY2023 · AI
Modeling approaches to prioritize TB prevention among people with HIV in Uganda
$94,236Jennifer M Ross · University Of Washington · K01 · FY2021 · AI
Genetic basis of metabolite production against clinically-derived pathogens
$94,209Hans Wildschutte · Bowling Green State University · R15 · FY2023 · GM
Analysis of cord blood Vd2 T cell differentiation and function using CITE-seq and ATAC-seq
$94,175Cristiana Cairo · University Of Maryland Baltimore · R03 · FY2024 · AI
Phosphotyrosine Recognition in Bacteria
$94,150Christoph Grundner · Seattle Children'S Hospital · R03 · FY2019 · AI
Modeling approaches to prioritize TB prevention among people with HIV in Uganda
$94,126Jennifer M Ross · University Of Washington · K01 · FY2022 · AI
Patient and system factors associated with successful treatment of Tuberculosis
$94,100Fernando Adriãn Rubinstein · Instituto De Efectividad Clinica Y Sanit · R01 · FY2010 · AI
Clinical Core
$94,053C Robert Horsburgh · Boston Medical Center · U19 · FY2014 · AI
Core--Early Preclinical Testing of Tuberculosis Drugs in Mice
$94,052Anne J. Lenaerts · Colorado State University · P01 · FY2008 · AI
Administrative Core B
$93,987Ronald J Falk · Univ Of North Carolina Chapel Hill · P01 · FY2016 · DK
Administrative Core B
$93,987Ronald J Falk · Univ Of North Carolina Chapel Hill · P01 · FY2015 · DK
Mali International Center for Excellence in Research: Filariasis
$93,968Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Occupational Health and Safety
$93,864Mark Alise · Tulane University Of Louisiana · P51 · FY2018 · OD
Occupational Health and Safety
$93,864Mark Alise · Tulane University Of Louisiana · P51 · FY2019 · OD
Characterizing the pharmacokinetics of high dose rifampicin and linezolid in a randomized controlled trial for HIV-associated tuberculous meningitis
$93,850Sean Adam Wasserman · University Of Cape Town · K43 · FY2019 · TW
Sigma factor networks of M. tuberculosis
$93,669Maria Laura Gennaro · Rbhs-New Jersey Medical School · R21 · FY2012 · AI
iTC200 MicroCalorimetry Cell Control Unit
$93,625Courtney C Aldrich · University Of Minnesota · S10 · FY2014 · OD
CELLULAR AND MOLECULAR BASIS OF GAMMA/DELTA T CELL ANTIGEN RECOGNITION
$93,598Kaushik Choudhuri · New York University School Of Medicine · K99 · FY2012 · AI
Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment
$93,590Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2025 · AI